Clinical Trials Sponsored by Lilly USA

Total 8029 results

Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
Ajinomoto USA, INC.

Completed

Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

Obesity | Overweight
Horizon Therapeutics USA, Inc.

Completed

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Thyroid Eye Disease | Chronic (Inactive) Thyroid Eye Disease

United States
Ricoh USA, Inc.

Recruiting

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Osteosarcoma | Sarcoma, Ewing | Chondrosarcoma | Fibrosarcoma | Fibrous Histiocytoma

United States
AnGes USA, Inc.

Recruiting

Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers

Peripheral Artery Disease | Chronic Limb Threatening Ischemia | Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease | Ischemic Ulcer of Foot

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.

Tinea Versicolor

United States
Medicrea, USA Corp.

Withdrawn

O-arm Assessment of Vertebral Movement Using ST2R Technique

Scoliosis; Adolescence
GenesisCare USA
Bayer

Withdrawn

Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC (CARE)

Metastatic Prostate Cancer
NDRI-USA, Inc.

Completed

National Fallen Firefighter Foundation's (NFFF) Stress First Aid Intervention

Mental Health Issue
Ribomic USA Inc

Completed

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration (RAMEN)

Exudative Age-related Macular Degeneration

United States
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

Healthy

United States
Salvacion USA Inc.

Completed

LAEH Formulation Nasal Spray to Reduce Viral Load

Coronavirus Disease

United States
Fibronostics USA, Inc

Completed

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver Steatoses

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Plaque Psoriasis

United States
XRHealth USA Inc.

Completed

Change in Pain With Virtual Reality-augmented Remote Rehabilitative Care

Musculoskeletal Pain

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Oxymetazoline 1% Cream to RHOFADE

Bioequivalence

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Tinea Pedis

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
AnGes USA, Inc.

Completed

A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

Critical Limb Ischemia

United States
Intercell USA, Inc.

Completed

Traveler's Diarrhea (TD) Automated Process

Prevention of Travelers' Diarrhea

United States
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 40 mg Tablets Food Challenge Study

Healthy

Canada
Taro Pharmaceuticals USA

Completed

A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

Secondarily Infected Traumatic Skin Lesions
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Scalp Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Psoriasis

United States
Taro Pharmaceuticals USA

Completed

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

Lice; Head Lice

United States
Medicrea, USA Corp.

Completed

Scoliosis Surgery Using the PASS® LP System

Idiopathic Scoliosis

United States
MEDRx USA, Inc.

Completed

Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain

Low Back Pain

United States
Taro Pharmaceuticals USA

Completed

Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis

Tinea Pedis
Taro Pharmaceuticals USA

Completed

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
MetaCure (USA), Inc.

Completed

The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

Diabetes Mellitus, Type 2

Austria, Germany, Italy, Poland
Taro Pharmaceuticals USA

Completed

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

Tinea Pedis

United States, Belize
Taro Pharmaceuticals USA

Completed

A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis

Tinea Pedis
Taro Pharmaceuticals USA

Completed

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

Pediculosis

India
Taro Pharmaceuticals USA

Completed

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea (MTZG)

Rosacea

United States
Taro Pharmaceuticals USA

Terminated

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Lice Infestations

United States
Intercell USA, Inc.

Completed

Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study

Traveler's Diarrhea

India, United Kingdom, Germany
Intercell USA, Inc.

Completed

ETEC Logistics Trial (TREK) (Trek)

Diarrhea

United States, Guatemala, Mexico
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Bioequivalence

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States
MetaCure (USA), Inc.

Terminated

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Overweight | Type 2 Diabetes Mellitus

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada

3

Subscribe